Table 1.
A summary of the clinical parameters of LDLT recipients
| EAD (N = 23) | Non-EAD (N = 51) | p-value | |
|---|---|---|---|
| PRE-OPERATIVE PARAMETERS | |||
| Age | 52.48 ± 10.20 | 56.45 ± 7.10 | 0.1004 |
| Height | 1.65 ± 0.09 | 1.62 ± 0.08 | 0.1383 |
| Weight | 68.74 ± 13.59 | 66.77 ± 11.34 | 0.5178 |
| BMI | 25.18 ± 3.77 | 25.39 ± 3.33 | 0.8153 |
| MELD | 21.22 ± 11.19 | 16.41 ± 8.37 | 0.0438 |
| Gender (F/M) | 6/17 | 25/26 | 0.0657 |
| Gender Mismatch | 16 | 23 | 0.0520 |
| Female to Male | 11 | 15 | 0.1281 |
| Blood Type | 0.9577 | ||
| A | 8 | 18 | |
| B | 5 | 11 | |
| O | 9 | 20 | |
| AB | 1 | 2 | |
| ABO Incompatibility | 3 | 8 | 0.7712 |
| Etiology | |||
| HBV | 11 | 23 | 0.8303 |
| HCV | 6 | 18 | 0.4405 |
| Alcoholism | 7 | 14 | 0.7956 |
| HCC | 6 | 23 | 0.1244 |
| INTRA-OPERATIVE PARAMETERS | |||
| Blood Loss (mL) | 2547.83 ± 1806.71 | 1712.16 ± 1552.97 | 0.0455 |
| RBC (units) | 11.61 ± 7.83 | 7.57 ± 7.16 | 0.0324 |
| FFP (units) | 15.48 ± 10.72 | 10.82 ± 10.34 | 0.0806 |
| Platelets (units) | 9.39 ± 8.83 | 8.24 ± 9.14 | 0.6124 |
| Graft Size (mg) | 626.78 ± 127.62 | 637.25 ± 140.63 | 0.7614 |
| GRWR (%) | 0.94 ± 0.18 | 0.98 ± 0.29 | 0.4050 |
| CIT (minutes) | 43.39 ± 30.07 | 51.49 ± 32.82 | 0.3171 |
| WIT (minutes) | 45.09 ± 26.66 | 50.02 ± 39.31 | 0.5307 |
| POST-OPERATIVE OUTCOMES | |||
| Mortality within 7 days | 2 | 0 | N/A |
| Mortality within 30 days | 5 | 1 | 0.0380 |
| Mortality within 60 days | 7 | 1 | 0.0090 |
| Mortality within 90 days | 8 | 2 | 0.0070 |
| In hospital Mortality | 8 | 3 | 0.0117 |
Abbreviations: EAD, early allograft dysfunction; BMI, body mass index; MELD, model for end-stage liver disease; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; PRBC, packed red blood cell; FFP, fresh frozen plasma; GRWR, graft recipient weight ratio; CIT, cold ischemia time; WIT, warm ischemia time; ICU, intensive care unit.